867324-12-7

867324-12-7 structure

Name: LBW242
Chemical Name: Propanamide, N-[(1S)-1-cyclohexyl-2-[(3aR,7aS)-octahydro-6-(2-phenylethyl)-1H-pyrrolo[2,3-c]pyridin-1-yl]-2-oxoethyl]-2-(methylamino)-, (2S)
CAS Number: 867324-12-7
Molecular Formula: C₂₇H₄₂N₄O₂
Molecular Weight: 454.64800
Catalog: Signaling Pathways Apoptosis IAP
Create Date: 2017-04-27 07:18:54
Modify Date: 2024-01-13 23:19:15
LBW242, a 3-mer and Smac mimetic, is a potent and orally active proapoptotic IAP inhibitor. LBW242 shows effects on mutant FLT3-expressing cells. LBW242 has activity against multiple myeloma[1].

Name	Propanamide, N-[(1S)-1-cyclohexyl-2-[(3aR,7aS)-octahydro-6-(2-phenylethyl)-1H-pyrrolo[2,3-c]pyridin-1-yl]-2-oxoethyl]-2-(methylamino)-, (2S)
Synonyms	lbw 242

Description	LBW242, a 3-mer and Smac mimetic, is a potent and orally active proapoptotic IAP inhibitor. LBW242 shows effects on mutant FLT3-expressing cells. LBW242 has activity against multiple myeloma[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Apoptosis >> IAP Signaling Pathways >> Protein Tyrosine Kinase/RTK >> FLT3
In Vitro	LBW242 is a 3-mer and Smac mimetic, based on the ability of the NH2-terminal seven amino acids of Smac to neutralize the BIR3 domain of X-chromosome-linked IAP (XIAP). LBW242 partially inhibits the growth of mutant FLT3-expressing lines, MV4;11 at 1μM[1]. LBW242 (0-0.1 μM; 3 days) inhibits a panel of PKC412-sensitive or PKC412-resistant, mutant FLT3-expressing Ba/F3 lines The IC50 values ranged from 0.5 to >1 μM[1]. Cell Viability Assay[1] Cell Line: FLT3-ITD-Ba/F3 cells and mutant FLT3-expressing cells, A627T-FLT3-Ba/F3, F691IFLT3-Ba/F3, and N676D-FLT3-Ba/F3 cells Concentration: 0.001, 0.01, 0.1 μM Incubation Time: 3 days Result: Inhibited a panel of PKC412-sensitive or PKC412-resistant, mutant FLT3-expressing Ba/F3 lines The IC50 values ranged from 0.5 to >1 μM .
In Vivo	LBW242 (50 mg/kg; p.o.; daily for 10 days) reduces tumor burden[1]. Animal Model: NCR nude mice were inoculated with FLT3-ITD-Ba/F3 cells[1] Dosage: 50 mg/kg Administration: Oral gavage; daily for 10 days Result: Effective in reducing tumor burden.
References	[1]. Weisberg E, et al. Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells. Mol Cancer Ther. 2007 Jul;6(7):1951-61.

Molecular Formula	C₂₇H₄₂N₄O₂
Molecular Weight	454.64800
Exact Mass	454.33100
PSA	64.68000
LogP	3.48250

1158522-08-7	940364-43-2
134104-43-1	131615-57-1
6906-52-1	930439-75-1
1018584-77-4	1375289-11-4
1499637-39-6	849349-65-1